Mantle Cell Lymphoma Pipeline Research Report 2024
04 juil. 2024 09h21 HE
|
Research and Markets
Dublin, July 04, 2024 (GLOBE NEWSWIRE) -- The "Mantle Cell Lymphoma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Mantle Cell Lymphoma-...
Findings from landmark RESONATE-2 study confirm sustained survival benefit of IMBRUVICA® (ibrutinib) for first-line chronic lymphocytic leukaemia treatment with up to 10 years follow-up
14 juin 2024 03h00 HE
|
Janssen Cilag International NV
RESONATE-2 data presented at the 2024 European Hematology Association (EHA) Congress provide longest-term outcomes and safety data ever reported for a monotherapy BTK inhibitor, with a median PFS of...
Ibrutinib Global Market Report 2024 - Ibrutinib Market Projected to Reach $41.98 Billion by 2028: In-depth Analysis Reveals North America Leads Growth
27 févr. 2024 11h22 HE
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Ibrutinib Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The ibrutinib market size is expected to see exponential...
Mantle Cell Lymphoma Therapeutics Market to Reach $3.29 Billion by 2028 with Innovations in Targeted Therapies
08 févr. 2024 11h42 HE
|
Research and Markets
Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "Mantle Cell Lymphoma Therapeutics Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The latest market research report...
The Launch of Emerging Therapies Will Significantly Impact the Waldenstrom Macroglobulinemia Market - Global Emerging Insights and Market Forecast to 2030
20 déc. 2021 05h43 HE
|
Research and Markets
Dublin, Dec. 20, 2021 (GLOBE NEWSWIRE) -- The "Waldenstrom Macroglobulinemia - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering....
Global Follicular Lymphoma Market and Epidemiology Landscape Report 2021-2030 - Discover the Drivers, Barriers, and Unmet Medical Needs to Curate the Best Opportunities
17 déc. 2021 07h13 HE
|
Research and Markets
Dublin, Dec. 17, 2021 (GLOBE NEWSWIRE) -- The "Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. This report...
Global Chronic Lymphocytic Leukemia (CLL) Disorder Clinical Market Report 2021-2027
06 juil. 2021 08h08 HE
|
Research and Markets
Dublin, July 06, 2021 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL)" report has been added to ResearchAndMarkets.com's offering. Chronic lymphocytic leukemia (CLL) is a disorder where...
Global Mantle Cell Lymphoma Treatment Market (2021 to 2029) - Featuring Amgen, Astellas Pharma and Biogen Among Others
17 juin 2021 07h53 HE
|
Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Mantle Cell Lymphoma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
Global Waldenstrom Macroglobulinemia (WM) Market Spotlight Report 2021: Bristol Myers Squibb, Johnson & Johnson, and Takeda Lead Industry Sponsors with the Highest Overall Number of Clinical Trials
08 juin 2021 07h58 HE
|
Research and Markets
Dublin, June 08, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Waldenstrom Macroglobulinemia (WM)" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers...
China Ibrutinib Markets, 2016-2020 & 2021-2025: A BTK Inhibitor Used to Treat B-cell Carcinomas
21 mai 2021 04h48 HE
|
Research and Markets
Dublin, May 21, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Ibrutinib Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Ibrutinib is a BTK inhibitor,...